• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[口腔鳞状细胞癌与口腔上皮发育异常:术前及术后诊断]

[Oral squamous cell carcinoma and oral epithelial dysplasia : Pre- and postoperative diagnostics].

作者信息

Liese Jan, Becker Anne-Sophie

机构信息

Klinik und Poliklinik für Mund‑, Kiefer- und Plastische Gesichtschirurgie, Universitätsmedizin Rostock, Rostock, Deutschland.

Institut für Pathologie, Universitätsmedizin Rostock, Strempelstr. 14, 18057, Rostock, Deutschland.

出版信息

Pathologie (Heidelb). 2025 May 27. doi: 10.1007/s00292-025-01435-9.

DOI:10.1007/s00292-025-01435-9
PMID:40425870
Abstract

Among non-cutaneous head and neck tumours, oral squamous cell carcinoma is one of the most common entities and is clinically characterized by functionally limiting therapies and a high recurrence rate. The majority of oral squamous cell carcinomas arise from potentially malignant diseases of the oral mucosa, which are often biopsied for preventive and diagnostic purposes. This article provides the histological criteria for grading oral epithelial dysplasia, with a scheme to help classify p53 staining and estimate prognosis. As oral cancer is still a morphologically defined entity, the histological subtypes and prognostic parameters that can be determined by light microscopy are presented. Future treatment approaches are outlined, which cannot be compared to other tumour entities due to the lack of therapeutically useful molecular alterations in oral squamous cell carcinoma.

摘要

在非皮肤性头颈部肿瘤中,口腔鳞状细胞癌是最常见的类型之一,其临床特征为功能受限的治疗方法和高复发率。大多数口腔鳞状细胞癌起源于口腔黏膜的潜在恶性疾病,这些疾病常因预防和诊断目的而进行活检。本文提供了口腔上皮发育异常分级的组织学标准,以及一个有助于对p53染色进行分类和评估预后的方案。由于口腔癌仍是一个形态学定义的实体,本文介绍了可通过光学显微镜确定的组织学亚型和预后参数。文中概述了未来的治疗方法,由于口腔鳞状细胞癌缺乏具有治疗意义的分子改变,这些方法无法与其他肿瘤类型相比较。

相似文献

1
[Oral squamous cell carcinoma and oral epithelial dysplasia : Pre- and postoperative diagnostics].[口腔鳞状细胞癌与口腔上皮发育异常:术前及术后诊断]
Pathologie (Heidelb). 2025 May 27. doi: 10.1007/s00292-025-01435-9.
2
Molecular profiling of oral epithelial dysplasia and oral squamous cell carcinoma using next generation sequencing.使用下一代测序技术对口腔上皮发育异常和口腔鳞状细胞癌进行分子分析。
J Stomatol Oral Maxillofac Surg. 2024 Oct 17;126(4):102120. doi: 10.1016/j.jormas.2024.102120.
3
Immunohistochemical Expression of PARK2 and YAP in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.PARK2和YAP在口腔上皮异常增生及口腔鳞状细胞癌中的免疫组化表达
Head Neck Pathol. 2025 Apr 25;19(1):50. doi: 10.1007/s12105-025-01790-2.
4
Clinico-Pathological Assessment and Malignant Transformation in Patients with Oral Epithelial Dysplasia - A Follow-up Cohort Study.口腔上皮发育异常患者的临床病理评估与恶性转化——一项随访队列研究
Head Neck Pathol. 2025 Aug 4;19(1):96. doi: 10.1007/s12105-025-01833-8.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.针对出现临床明显病变的患者进行口腔癌及潜在恶性疾病的诊断测试。
Cochrane Database Syst Rev. 2015 May 29;2015(5):CD010276. doi: 10.1002/14651858.CD010276.pub2.
7
Efficacy of light based detection systems for early detection of oral cancer and oral potentially malignant disorders: Systematic review.基于光的检测系统在口腔癌及口腔潜在恶性疾病早期检测中的效能:系统评价
Med Oral Patol Oral Cir Bucal. 2016 Jul 1;21(4):e447-55. doi: 10.4317/medoral.21104.
8
The landscape of long non-coding RNA during cSCC progression.皮肤鳞状细胞癌进展过程中长链非编码RNA的情况
Br J Dermatol. 2025 Mar 27. doi: 10.1093/bjd/ljaf108.
9
Critical update, systematic review, and meta-analysis of oral erythroplakia as an oral potentially malignant disorder.口腔红斑作为一种口腔潜在恶性疾病的重要更新、系统评价和荟萃分析。
J Oral Pathol Med. 2022 Aug;51(7):585-593. doi: 10.1111/jop.13304. Epub 2022 May 12.
10
Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.小体积原发性口咽癌的微创手术与放疗/放化疗对比
Cochrane Database Syst Rev. 2016 Dec 11;12(12):CD010963. doi: 10.1002/14651858.CD010963.pub2.

本文引用的文献

1
The role of molecular biomarkers in the diagnosis, prognosis, and treatment stratification of oral squamous cell carcinoma: A comprehensive review.分子生物标志物在口腔鳞状细胞癌诊断、预后及治疗分层中的作用:一项综述。
J Liq Biopsy. 2025 Jan 4;7:100285. doi: 10.1016/j.jlb.2025.100285. eCollection 2025 Mar.
2
Diagnostic Criteria for Oral Epithelial Dysplasia: Predicting Malignant Transformation.口腔上皮发育异常的诊断标准:预测恶性转化
Head Neck Pathol. 2025 Feb 7;19(1):21. doi: 10.1007/s12105-025-01754-6.
3
p53 Abnormal Oral Epithelial Dysplasias are Associated With High Risks of Progression and Local Recurrence-A Retrospective Study in a Longitudinal Cohort.
p53异常的口腔上皮发育异常与进展和局部复发的高风险相关——一项纵向队列的回顾性研究
Mod Pathol. 2024 Dec;37(12):100613. doi: 10.1016/j.modpat.2024.100613. Epub 2024 Sep 10.
4
Perineural Invasion Is a Significant Prognostic Factor in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.神经周围浸润是口腔鳞状细胞癌的一个重要预后因素:一项系统评价和荟萃分析
Diagnostics (Basel). 2023 Oct 30;13(21):3339. doi: 10.3390/diagnostics13213339.
5
Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia.开发和验证用于预测口腔上皮异型增生恶性转化和复发的多变量模型。
Br J Cancer. 2023 Nov;129(10):1599-1607. doi: 10.1038/s41416-023-02438-0. Epub 2023 Sep 27.
6
Abnormal p53 Immunohistochemical Patterns Shed Light on the Aggressiveness of Oral Epithelial Dysplasia.异常的p53免疫组化模式揭示口腔上皮发育异常的侵袭性
Mod Pathol. 2023 Jul;36(7):100153. doi: 10.1016/j.modpat.2023.100153. Epub 2023 Mar 9.
7
Histopathological parameters reported in microinvasive oral squamous cell carcinoma: a systematic review.微浸润性口腔鳞状细胞癌的组织病理学参数:系统评价。
Med Oral Patol Oral Cir Bucal. 2023 May 1;28(3):e255-e263. doi: 10.4317/medoral.25675.
8
Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer.癌症中范可尼贫血 DNA 修复途径缺陷的基因组特征。
Nature. 2022 Dec;612(7940):495-502. doi: 10.1038/s41586-022-05253-4. Epub 2022 Nov 30.
9
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.帕博利珠单抗联合或不联合化疗治疗复发性或转移性头颈部鳞状细胞癌:III 期 KEYNOTE-048 研究的更新结果。
J Clin Oncol. 2023 Feb 1;41(4):790-802. doi: 10.1200/JCO.21.02508. Epub 2022 Oct 11.
10
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.纳武利尤单抗联合伊匹单抗新辅助免疫治疗可诱导头颈部鳞状细胞癌患者发生主要病理缓解。
Nat Commun. 2021 Dec 22;12(1):7348. doi: 10.1038/s41467-021-26472-9.